Displaying items 7081-7100 of 47199 in total

Gulf Investors Return to US Real Estate, But Now They Call the Shots

Read full article
Gulf Investors Return to US Real Estate, But Now They Call the Shots

LifeLock Founder's New Gamble: Can a Virtual Health Share Fix Healthcare?

Read full article
LifeLock Founder's New Gamble: Can a Virtual Health Share Fix Healthcare?

Safi Silver's Gambit: Warrant Restructure and Board Shakeup Fuel Africa Push

Read full article
Safi Silver's Gambit: Warrant Restructure and Board Shakeup Fuel Africa Push

The 40,000-Resource Classroom: Ed-Tech's Push for Personalized Learning

Read full article
The 40,000-Resource Classroom: Ed-Tech's Push for Personalized Learning

GoCharting's Gambit: Can a Free Competition Forge Professional Traders?

Read full article
GoCharting's Gambit: Can a Free Competition Forge Professional Traders?

MedTech's AI Paradox: Reps Save Time But Miss the Strategic Mark

Read full article
MedTech's AI Paradox: Reps Save Time But Miss the Strategic Mark

Beyond the Trophy: Amsted's Blueprint for Manufacturing Excellence

Read full article
Beyond the Trophy: Amsted's Blueprint for Manufacturing Excellence

A Bouillon Giant and Noodle Innovator Target Costco for Ramen Disruption

Read full article
A Bouillon Giant and Noodle Innovator Target Costco for Ramen Disruption

Kura's Darlifarnib: A Catalyst for a New Era in Cancer Combination Therapy?

Read full article
Kura's Darlifarnib: A Catalyst for a New Era in Cancer Combination Therapy?

The Berlin-to-U.S. Playbook: Pliant's Bid to Reshape B2B Payments

Read full article
The Berlin-to-U.S. Playbook: Pliant's Bid to Reshape B2B Payments

A Clearer Future? Eye Drop for Cataracts Enters Key U.S. Clinical Trial

Read full article
A Clearer Future? Eye Drop for Cataracts Enters Key U.S. Clinical Trial

Beyond the Alert: Why the Endace-Vectra AI Alliance Reshapes Security

Read full article
Beyond the Alert: Why the Endace-Vectra AI Alliance Reshapes Security

Mighty Therapeutics Lands $150M to Scale Breakthrough Mitochondrial Drugs

Read full article
Mighty Therapeutics Lands $150M to Scale Breakthrough Mitochondrial Drugs

Beyond the Default: Opera's Growth Signals a Shift in User Intent

Read full article
Beyond the Default: Opera's Growth Signals a Shift in User Intent

Cresset's New CTO: A High-Stakes Bet on Institutional Tech Power

Read full article
Cresset's New CTO: A High-Stakes Bet on Institutional Tech Power

ARCO's Capital Play: Design-Build Giant Targets D.C.'s Innovation Economy

Read full article
ARCO's Capital Play: Design-Build Giant Targets D.C.'s Innovation Economy

Innoviz's LiDAR Jumps from Luxury Cars to the Front Lines of Defense

Read full article
Innoviz's LiDAR Jumps from Luxury Cars to the Front Lines of Defense

The No-Code AI Revolution: Frigade Equips Software with Actionable Agents

Read full article
The No-Code AI Revolution: Frigade Equips Software with Actionable Agents

Vesalio's Strategic Hire Signals Major Push in Clot-Busting Market

Read full article
Vesalio's Strategic Hire Signals Major Push in Clot-Busting Market

SOGOAPP's Gambit: Can Privacy and Profit Coexist in Social Media?

Read full article
SOGOAPP's Gambit: Can Privacy and Profit Coexist in Social Media?